Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARVEDILOL Cause Product substitution issue? 210 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Product substitution issue have been filed in association with CARVEDILOL (Carvedilol Phosphate). This represents 1.5% of all adverse event reports for CARVEDILOL.

210
Reports of Product substitution issue with CARVEDILOL
1.5%
of all CARVEDILOL reports
3
Deaths
31
Hospitalizations

How Dangerous Is Product substitution issue From CARVEDILOL?

Of the 210 reports, 3 (1.4%) resulted in death, 31 (14.8%) required hospitalization, and 9 (4.3%) were considered life-threatening.

Is Product substitution issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARVEDILOL. However, 210 reports have been filed with the FAERS database.

What Other Side Effects Does CARVEDILOL Cause?

Hypotension (1,822) Dyspnoea (1,143) Dizziness (1,138) Drug ineffective (1,102) Fatigue (1,020) Completed suicide (1,019) Bradycardia (861) Toxicity to various agents (690) Cardiac failure (636) Asthenia (562)

What Other Drugs Cause Product substitution issue?

AMPHETAMINE ASPARTATE\AMPHETAMINE\DEXTROAMPHETAMINE SACCHARATE\DEXTROAMPHETAMINE (2,832) BUPROPION (1,578) METHYLPHENIDATE (1,408) CLONAZEPAM (1,288) LAMOTRIGINE (979) ALBUTEROL (864) LEVOTHYROXINE (803) DULOXETINE (766) ESTRADIOL (692) SERTRALINE (636)

Which CARVEDILOL Alternatives Have Lower Product substitution issue Risk?

CARVEDILOL vs CASIMERSEN CARVEDILOL vs CASIRIVIMAB CARVEDILOL vs CASIRIVIMAB\IMDEVIMAB CARVEDILOL vs CASPOFUNGIN CARVEDILOL vs CATEQUENTINIB

Related Pages

CARVEDILOL Full Profile All Product substitution issue Reports All Drugs Causing Product substitution issue CARVEDILOL Demographics